Equities Market Recap: Stocks Reach Multi-Year Highs on Bernanke Announcement

Brittney Barrett  |

The three major U.S. indexes surged today, breaking multi-year records after Federal Reserve Chairman Ben Bernanke announced the central bank would prolong reinvestment of proceeds from maturing securities and assured there were no immediate plans to tighten interest rates.

The Dow Jones Industrial Average shot up 95.59 points, or 0.8 percent to 12690.96, while the Standard & Poor's 500-stock index added 8.42 points, or 0.6 percent, to 1355.66. The Nasdaq Composite tacked on 22.34 points, or 0.8 percent, to 2869.88.

Bernanke’s statement elucidated the Fed’s intention to continue with monetary stimulation after the latest bond buying and the market’s have responded positively.

Tech stocks made major gains today with shares of Amazon (NASDAQ:AMZN) up 8 percent at close after sales were higher than expected. JDA Software Group Inc. (NASDAQ: JDAS) also added 12.6 percent as a result of earnings in excess of Wall Street expectations. Polycom Inc. (NASDAQ: PLCM) closed 4.71 percent higher, continuing to rally following its sunny earnings report last week.

Breaking patterns for the broader sector, chip maker Broadcom Corp. (NASDAQ: BRCM) fell 12.3 percent have releasing forecasts for second-quarter sales that were beneath Wall Street expectations.

 

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
LNG Cheniere Energy Inc. 67.30 0.59 0.88 3,706,409
JNJ Johnson & Johnson 140.46 -0.08 -0.06 5,049,937 Trade

Comments

Emerging Growth

IMV Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.